Jang, Y., Bellier, N., Canlas, K. K. V., Lee, J. Y., Kim, Y., Park, H., & Moon, J. J. (2026). Simulation-guided design of peptide–metal coordination interfaces for next-generation metallo-immunotherapy. Nano Convergence, 13(1), 14.

Jang, Y., Babu, A., Chahal, S., Vasukutty, A., J. Moon, J., Park, I. K., & Park, H. (2025). AI-guided design of a CXCR4-targeted core-shell nanocarrier for co-delivery of berberine/paclitaxel in cancer therapy. Journal of nanobiotechnology, 23(1), 773.

Bellier, N., Jang, Y., Canlas, K. K. V., & Park, H. (2025). Architectural design of biomaterial scaffolds for hematopoietic stem cell culture. Biomaterials Research, 29, 0253.

Jang, Y., & Park, H. (2025). CXCR4-binding peptide-functionalized M1 macrophage vesicle-coated micelles for enhanced targeting and 6BIO-mediated cancer combination therapy. Applied Surface Science, 695, 162745.

Vasukutty, A., Jang, Y., Han, D., Park, H., & Park, I. K. (2024). Navigating latency-inducing viral infections: therapeutic targeting and nanoparticle utilization. Biomaterials research, 28, 0078.

Jang, Y., Cho, Y. S., Kim, A., Zhou, X., Kim, Y., Wan, Z., ... & Park, H. (2024). CXCR4-targeted macrophage-derived biomimetic hybrid vesicle nanoplatform for enhanced cancer therapy through codelivery of manganese and doxorubicin. ACS applied materials & interfaces, 16(14), 17129-17144.

Jang, Y., Kim, A., Moon, J. J., Lee, J. Y., & Park, H. (2023). Novel bioengineering strategies for drug delivery systems. Applied materials today, 33, 101834.

Hong, J., Choi, Y., Lee, G., Kim, J., Jang, Y., Yoon, C. H., ... & Choi, J. (2023). Nanosome‐Mediated Delivery Of Hdac Inhibitors and Oxygen Molecules for the Transcriptional Reactivation of Latent Hiv‐Infected Cd4+ T Cells. Small, 19(37), 2301730.

​Muhammad, Q., Jang, Y., Kang, S. H., Moon, J., Kim, W. J., & Park, H. (2020). Modulation of immune responses with nanoparticles and reduction of their immunotoxicity. Biomaterials science, 8(6), 1490-1501.